CTX-203

N/A

Report date: 2024/11/14 16:49:47

NME

Base Information

Drug NameCTX-203

Drug Alias NameCTX203CTX-203

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionApolipoproteins agonists

TargetsApolipoproteins

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCharacter Biosciences

China Registration ClassN/A

Develop Information

Active CompaniesCharacter Biosciences

Inactive CompaniesN/A

Active IndicationsMacular Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A